FDA Adverse Event Injury Summary report: N

SYNCHROMED

MDR report key: 1082129 · Received July 24, 2008

Report

Report Number
2182207-2008-04343
Event Type
Injury
Date Received
July 24, 2008
Report Date
June 26, 2008
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
LKK
PMA / PMN Number
P860004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

RESULTS: CATHETER. SEE SCANNED PAGES.

Description of Event or Problem · 1

JOURNAL REFERENCE: RAMSEY C N, OWEN RD, WITT WO, GRIDER, JS. INTRATHECAL GRANULOMA IN A PT RECEIVING HIGH DOSE HYDROMORPHONE: PAIN PHYSICIAN 2008; 11:3:369-373. IN THE CURRENT CASE WE REPORT THE EVAL AND MANAGEMENT OF AN INTRATHECAL GRANULOMA IN A PT RECEIVING A RELATIVELY HIGH CONCENTRATION OF INTRATHECAL HYDROMORPHONE. THOUGH USE OF INTRATHECAL HYDROMORPHONE STILL REPRESENTS AN OFF LABEL APPLICATION, THIS OPIATE IS COMMONLY EMPLOYED AS AN ALTERNATIVE FIRST LINE ANALGESIC AGENT. RAPIDLY DECLINING NEUROLOGIC FUNCTION WITH A CONFIRMED INFLAMMATORY MASS ADHERENT TO THE SPINAL CANAL NECESSITATED URGENT SURGICAL INTERVENTION. REPORTABLE EVENT: WE PRESENT THE CASE OF A MALE WITH A HISTORY OF CHRONIC LUMBAR SPINE PAIN. THE PT HAD RECEIVED AN INTRATHECAL DRUG DELIVERY SYSTEM 8 YRS AGO. MORPHINE WAS THE INITIAL DRUG CHOSEN FOR THERAPY, HOWEVER APPROX 2 YRS AGO HE RECALLS BEING SWITCHED TO HYDROMORPHONE. HE WAS REFERRED TO OUR INSTITUTION FOR EVAL WITH INCREASING BACK PAIN AND GAIT INSTABILITY IN THE PRECEDING 4 WKS, AS WELL AS URINARY RETENTION AND WEAKNESS IN THE LOWER EXTREMITIES. A MRI AND CT SCAN REVEALED AN INTRADURAL-EXTRAMEDULLARY LESION. THE PT WAS TAKEN TO THE OR FOR DECOMPRESSIVE LAMINECTOMY AND EXPLORATION WHICH SHOWED A 1CM MASS ADHERENT TO THE SPINAL CORD, ADJACENT TO THE TIP OF THE INTRATHECAL CATHETER. ONCE THE LESION WAS DETERMINED TO BE AN INFLAMMATORY MASS, IT WAS CAREFULLY DISSECTED AWAY FROM THE SPINAL CORD. ALL CULTURES OF THE SPECIMENS WERE NEGATIVE AND THE PT WAS DISCHARGED HOME AFTER 2 DAYS WITH A STABLE BUT IMPROVING NEUROLOGIC EXAM. AT 4 MONTHS POSTOPERATIVELY, HE HAD PERSISTENT NUMBNESS IN HIS LOWER EXTREMITIES AND ELECTED TO HAVE THE IDDS REMOVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SYNCHROMED LKK MEDTRONIC NEUROMODULATION UNK NA

Patients

Seq Age Sex Outcome Treatment
1 52 YR Other| R PROGRAMMER MODEL UNK N=1| CATHETER MODEL UNK N=1